Clinical Trial Update: Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and safety of allogeneic mesenchymal stem cells for chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Chronic Graft Versus Host Disease | Phase 2, Phase 3 | Status: UNKNOWN